Business Description
Histogen Inc
NAICS : 541714
SIC : 2833
ISIN : US43358Y2028
Description
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.52 | |||||
9-Day RSI | 84.9 | |||||
14-Day RSI | 62.23 | |||||
6-1 Month Momentum % | -33.33 | |||||
12-1 Month Momentum % | -99.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -53026.32 | |||||
OCF Margin % | -53021.05 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 14.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HSTOQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Histogen Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.019 | ||
| EPS (TTM) ($) | -2.81 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 5.67 | ||
| Volatility % | 1918.18 | ||
| 14-Day RSI | 62.23 | ||
| 14-Day ATR ($) | 0.000229 | ||
| 20-Day SMA ($) | 0.000268 | ||
| 12-1 Month Momentum % | -99.2 | ||
| 52-Week Range ($) | 0.0002 - 0.19 | ||
| Shares Outstanding (Mil) | 4.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Histogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Histogen Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 136 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 45 days | ||
| General meeting for 2025 | 2026-06-01 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-15 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-15 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-03-13 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-13 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2026-01-08 | 0.00 (+0.00%) | ||
| General meeting for 2024 | 2026-01-06 | 0.00 (+0.00%) |
Show
Entries
Histogen Inc Frequently Asked Questions
What is Histogen Inc(HSTOQ)'s stock price today?
The current price of HSTOQ is $0.00. The 52 week high of HSTOQ is $0.19 and 52 week low is $0.00.
When is next earnings date of Histogen Inc(HSTOQ)?
The next earnings date of Histogen Inc(HSTOQ) is 2026-08-14 Est..
Does Histogen Inc(HSTOQ) pay dividends? If so, how much?
Histogen Inc(HSTOQ) does not pay dividend.
Guru Commentaries on OTCPK:HSTOQ
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| DLA Piper advises Histogen in its US$14 million upsized public offering | 2021-01-07 |
Articles on Histogen Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers